Marshall Wace, LLP Sab Biotherapeutics Inc Wt Exp Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Marshall Wace, LLP holds 247,576 shares of SABSW stock, worth $7,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares
247,576
Holding current value
$7,427
% of portfolio
0.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

Others Institutions Holding SABSW

# of Institutions
12
Shares Held
354K
Call Options Held
602K
Put Options Held
0
View Full List

About SAB BIOTHERAPEUTICS INC WT EXP

SABSW Quotes by TradingView
  • Ticker SABSW
  • Sector Healthcare
  • Industry Biotechnology
More about SABSW
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email